Haijing Yang - Research Ward of Huashan Hospital, Fudan University

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, Tolerability, and Immunogenicity of a DNA Vaccine (pgx9501) Against SARS-CoV-2 in Healthy Volunteers: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, and Dose-Ranging Phase I Trial

Haijing Yang, Yang Zhou, Xin Cheng,Chao Qiu, Shuo Wang, Yu Xia, Xuefen Huai, Zhenning Xiu, Jiarong Wang, Yue He,Guoying Cao,Qiong Wei,Jingjing Wang,Jingwen Ai, Haochen Zhang,Yi Zhang,Jing Zhang,Wenhong Zhang,Bin Wang

Vaccinesno. 6 (2025): 573

引用0浏览0引用

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Cefiderocol in Chinese Healthy Subjects

Chuhan Zhang, Shuyan Yu,Size Li,Xiaojie Wu,Qiong Wei,Jinjie He,Guoying Cao,Haijing Yang, Jingjing Wang, Kohei Fujitani,Takayuki Katsube,Jing Zhang, Honghong Dou

Advances in Therapyno. 5 (2025): 2285-2297

引用0浏览0WOS引用

Lefamulin Dosing Optimization Using Population Pharmacokinetic and Pharmacokinetic/pharmacodynamic Assessment in Chinese Patients with Community-Acquired Bacterial Pneumonia

Xingchen Bian,Nanyang Li,Yi Li, Xu Zhu,Jicheng Yu,Yingying Hu,Haijing Yang,Qiong Wei,Xiaojie Wu,Jingjing Wang,Guoying Cao,Jufang Wu, Yang Wang,Jing Zhang

FRONTIERS IN PHARMACOLOGY (2024)

引用0浏览0WOS引用

First-in-Human Study of BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody in Patients with Neuromyelitis Optica Spectrum Disorders

Hai Yu,Yuancheng Chen, Yunpeng Qi,Haijing Yang,Guoying Cao, Wenbo Yang,Size Li,Xiaolei Yang, Hai Wang,Jing Zhang,Xiangjun Chen

CNS NEUROSCIENCE & THERAPEUTICSno. 11 (2024)

引用0浏览0WOS引用

Pharmacokinetics and Safety of Mavacamten in Healthy Chinese Participants with Different CYP2C19 Phenotypes

Xiaojie Wu,Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang,Merali Samira,Qiong Wei,Jicheng Yu,Guoying Cao,Haijing Yang,Lili Wang,Jingjing Wang,Yi Jin, Wei Liu,Jufang Wu,Jinjie He,Cheng Lyu,Jing Zhang

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 7 (2024)

引用1浏览0WOS引用

Pharmacokinetics and Safety of EVER206, a Novel Polymyxin Antimicrobial, in Healthy Chinese Subjects

Size Li, Xu Zhu,Guoying Cao, Jufang Shen,Jicheng Yu,Xiaojie Wu,Jufang Wu,Haijing Yang,Nanyang Li,Yingying Hu,Jingjing Wang,Haihui Huang,Jing Zhang

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2024）

引用1浏览0WOS引用

A Randomised, Double-Blind, Placebo-Controlled, First-in-human Phase I Study to Characterise the Safety, Pharmacokinetics and Immunogenicity of 9MW1411 in Healthy Chinese Subjects

Haijing Yang, Peipei Wang,Xin Li,Qiong Wei,Jicheng Yu,Xiaojie Wu,Ying Huang, Ruowan Li,Weijuan Du,Shaoqing Zeng,Hailan Wu,Shuhai Wang,Jing Zhang

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTSno. 2 (2024)

引用0浏览0WOS引用

Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: an Open-Label, Phase I Study

Guoying Cao,Haijing Yang,Jingjing Wang,Masahiro Ishida,Christian Thoma,Thomas Haeufel, Sebastian Bossert,Jing Zhang

Advances in Therapy (2024)

引用0浏览0WOS引用

Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects

Yuran Cao,Xiaojie Wu,Zhiqiang Wang,Yuxian Huang,Junzhen Wu,Guoying Cao,Jicheng Yu,Jingjing Wang,Haijing Yang,Wenhong Zhang,Jing Zhang

Antimicrobial Agents and Chemotherapy（2023）

引用0浏览0WOS引用

Safety and Pharmacokinetics of IBI112, an IL-23 Monoclonal Antibody, in Chinese Healthy Volunteers: a First-in-human Phase 1 Study

Jinjie He,Weijuan Du,Haijing Yang,Jingjing Wang,Chenghang Cai,Qingyang Ma,Nanyang Li,Jicheng Yu,Xiaojie Wu,Jufang Wu,Yuancheng Chen,Guoying Cao,Jing Zhang

EXPERT OPINION ON INVESTIGATIONAL DRUGSno. 7 (2023): 669-675

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn